The Medicines and Healthcare products Regulatory Agency has approved imlunestrant tosylate, branded as Inluriyo, for adults ...
Verdiva Bio has completed enrolment for its phase 2b EVOLVE‑2 clinical study of VRB‑101, a once‑weekly oral GLP‑1 peptide analog being developed for body‑weight reduction in people with overweight or ...
AlzeCure Pharma has announced that the European Medicines Agency has granted orphan drug status to ACD440, its clinical‑stage ...
ViiV Healthcare has announced new 96‑week findings from a sub‑group analysis of the PASO DOBLE study, showing that adults ...
The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as ...
Lario Therapeutics has secured $2.4 million in new grant funding from The Michael J Fox Foundation for Parkinson’s Research ...
Johnson & Johnson has reported new long‑term results from the QUASAR long‑term extension study, showing that Tremfya (guselkumab) sustained clinical, endoscopic and histologic outcomes through week ...
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced ...
Lundbeck A/S has announced encouraging new data from the intravenous part of its phase 2b PROCEED trial, showing that ...
The European Life Sciences Coalition has been launched in Brussels with the aim of strengthening Europe’s life sciences and ...
GSK has secured European Commission approval for Exdensur (depemokimab) to treat severe asthma with type 2 inflammation and ...
Mikrobiomik has become the first organisation in Spain to receive authorisation to prepare and process faecal microbiota for treating Clostridioides difficile infection, following approval of its oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results